Press Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Archives: Search / 2021 / 2020 / 2019 / 2018 / 2017 / 2016 / 2015 / 2014 / 2013

 
From
To
Apr 20, 2021
DarioHealth Partners with MediOrbis on Virtual Care Offering for Diabetes

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis, a telehealth provider...

More
Mar 10, 2021
DarioHealth (DRIO) CEO Erez Raphael's Company Overview And Outlook | TD Ameritrade Network

Oliver Renick hosts Erez Raphael, the CEO of the global digital therapeutics company DarioHealth (DRIO) to discuss recent 4Q earnings results and the firm's outlook going forward.

More
Mar 9, 2021
DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and...

More
Mar 5, 2021
DarioHealth Announces Participation in Stephens Virtual Best Ideas Conference

DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company will participate in the upcoming Stephens 2021 Best Ideas Conference...

More
Mar 2, 2021
DarioHealth Study Examines Connection Between Personalization and Sustained Behavior Change in Digital Health

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the results of a new clinical study that have been published in the Journal of Medical...

More
Mar 1, 2021
DarioHealth to Report Fourth Quarter and Full Year 2020 Results on Tuesday, March 9

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December...

More
Feb 23, 2021
DarioHealth Announces Participation in the Cowen 41st Annual Healthcare Conference

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming Cowen 41st Annual Health Care...

More
Feb 19, 2021
DarioHealth to Participate in 10th Annual SVB Leerink Global Healthcare Conference

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host...

More
Jan 27, 2021
DarioHealth Announces Acquisition of Leading Digital Musculoskeletal Company Upright Technologies and $70 Million Financing

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company...

More
Jan 21, 2021
DarioHealth Announces Hiring of Leading Digital Health Innovator as Senior Vice President of Employer Sales

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. Mr. Chan will...

More
Jan 13, 2021
Diabetes and Behavioral Health Global Experts Join DarioHealth Scientific Advisory Board Expanding Innovation Leadership in Digital Therapeutics for Chronic Care

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its...

More
Jan 7, 2021
DarioHealth Appoints Claudia Rimerman Kraut as Vice President of Broker and Consultant Partnerships

DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Claudia Rimerman Kraut as Vice President of Broker and Consultant...

More
Jan 5, 2021
DarioHealth's Digital Therapeutics Solution Selected as Employee Health Benefit by Self-Insured, Fortune 500 Subsidiary

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its digital therapeutics...

More
Dec 22, 2020
DarioHealth Announces Agreement with Presbyterian Medical Services for Remote Patient Monitoring

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its remote patient monitoring...

More
Nov 24, 2020
DarioHealth's Digital Therapeutics Solution Selected as Employee Health Benefit by Self-Insured, Fortune 500 Company

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible...

More
1-25      26-50      51-75      76-100      101-125      126-150      151-175      176-200      201-225      226-250      251-275      276-300      301-325      326-350      351-375      376-387